Arkema Sa Stock Performance

ARKAF Stock  USD 60.48  0.00  0.00%   
Arkema SA has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.0032, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Arkema SA are expected to decrease at a much lower rate. During the bear market, Arkema SA is likely to outperform the market. Arkema SA right now shows a risk of 0.37%. Please confirm Arkema SA information ratio, as well as the relationship between the skewness and day median price , to decide if Arkema SA will be following its price patterns.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Arkema SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Arkema SA is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow1.6 B
Total Cashflows From Investing Activities473 M
  

Arkema SA Relative Risk vs. Return Landscape

If you would invest  5,987  in Arkema SA on October 14, 2025 and sell it today you would earn a total of  61.00  from holding Arkema SA or generate 1.02% return on investment over 90 days. Arkema SA is currently producing 0.017% returns and takes up 0.3708% volatility of returns over 90 trading days. Put another way, 3% of traded pink sheets are less volatile than Arkema, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Arkema SA is expected to generate 6.55 times less return on investment than the market. But when comparing it to its historical volatility, the company is 1.89 times less risky than the market. It trades about 0.05 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 of returns per unit of risk over similar time horizon.

Arkema SA Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Arkema SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Arkema SA, and traders can use it to determine the average amount a Arkema SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0459

High ReturnsBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsARKAF
Based on monthly moving average Arkema SA is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arkema SA by adding it to a well-diversified portfolio.

Arkema SA Fundamentals Growth

Arkema Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Arkema SA, and Arkema SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arkema Pink Sheet performance.

About Arkema SA Performance

By analyzing Arkema SA's fundamental ratios, stakeholders can gain valuable insights into Arkema SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Arkema SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Arkema SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19441 people.

Things to note about Arkema SA performance evaluation

Checking the ongoing alerts about Arkema SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Arkema SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating Arkema SA's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Arkema SA's pink sheet performance include:
  • Analyzing Arkema SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arkema SA's stock is overvalued or undervalued compared to its peers.
  • Examining Arkema SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Arkema SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arkema SA's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Arkema SA's pink sheet. These opinions can provide insight into Arkema SA's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Arkema SA's pink sheet performance is not an exact science, and many factors can impact Arkema SA's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Arkema Pink Sheet analysis

When running Arkema SA's price analysis, check to measure Arkema SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema SA is operating at the current time. Most of Arkema SA's value examination focuses on studying past and present price action to predict the probability of Arkema SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arkema SA's price. Additionally, you may evaluate how the addition of Arkema SA to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data